piperidine has been researched along with ceritinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Achary, R; Ahn, S; Cho, SY; Ha, JD; Hwang, JY; Jung, HJ; Kang, CH; Kim, HR; Kim, P; Lee, CO; Lee, HK; Lee, HY; Lee, JY; Mathi, GR; Park, CH; Yun, CS | 1 |
1 other study(ies) available for piperidine and ceritinib
Article | Year |
---|---|
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R.
Topics: Amines; Anaplastic Lymphoma Kinase; Animals; Crizotinib; Drug Resistance, Neoplasm; Heterografts; Humans; Mice; Mutation; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Sulfones | 2017 |